Evidence map›Paper›PMID 27246972›Full record

ArticleOncotarget2016

Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response.

Rong Yan, Kun Zhu, Chengxue Dang, Ke Lan, Haonan Wang, Dawei Yuan, Wei Chen, Stephen J Meltzer, Kang Li

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. NFATc3 Enhances DREAM Complex-Driven Transactivation.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. A FRET-Based Assay for the Identification of PCNA Inhibitors.International journal of molecular sciences · 2023
    Article
  5. Synergistic effect of PAF inhibition and X-ray irradiation in non-small cell lung cancer cells.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rong YanDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Kun ZhuDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Chengxue DangDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Ke LanDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Haonan WangDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Dawei YuanDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Wei ChenDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Stephen J MeltzerDepartment of Medicine (GI Division) and Oncology, Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Kang LiDepartment of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNSidney Kimmel Comprehensive Cancer Center · US

Funding

Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
Comprehensive Biomarker Development in early EsophagogasU01CA085069 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MELTZER, STEPHEN J · 1999 to 2009
$4.8M
(PQC-1) Driver Events In IBD-Associated Neoplastic ProgressionR01CA190040 · NCI · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J, SELARU, FLORIN · 2014 to 2017
$2.5M
The temporal epigenomic program of Barrett's neoplastic progressionR01DK087454 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J · 2009 to 2013
$1.8M
Inflammatory Bowel Disease-Associated Malignant TransformationR01CA133012 · NCI · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA133012NCI NIH HHS R01 CA190040NCI NIH HHS U01 CA085069NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R01 DK087454
6 · The paper itself

Abstract

Paf15, which participates in DNA repair, is overexpressed in numerous solid tumors. Blocking of Paf15 inhibits the growth of many types of cancer cells; while simultaneously enhancing cellular sensitivity to UV radiation. However, its expression and function in rectal cancer (RC) remain unknown. The current study was undertaken to assess the association of Paf15 expression with RC prognosis, as well as to explore the participation of Paf15 in the response of RC cells to irradiation. Increased Paf15 expression was observed in RC tissues and associated with pTNM stage and poor survival. In vitro, Paf15 induced increased RC cell proliferation while accelerating cell cycle progression, inhibiting cell death, and protecting against gamma radiation-induced DNA damage in RC cells. In conclusion, increased Paf15 expression is associated with increased RC proliferation, decreased patient survival, and a worse radiotherapeutic response.

Indexed as

DNA RepairGene Expression Regulation, NeoplasticAgedCarrier ProteinsCell CycleCell DeathCell Line, TumorCell ProliferationCell SurvivalDNA-Binding ProteinsDNA DamageFemaleHumansMaleMiddle AgedPrognosisCarrier ProteinsDNA-Binding ProteinsPCLAF protein, humancell cyclegamma radiationPaf15prognostic factorrectal cancer

Identifiers

PMID27246972
PMCPMC5122426
OpenAlexW2407592363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.